Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease.

G. Schürmann(Harvard University), J. M. Polak(Hammersmith Hospital), J C Lee(London Postgraduate Medical and Dental Education), Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), A.E. Bishop(Hammersmith Hospital), David S. Rampton(Royal London Hospital), P. Facer(London Postgraduate Medical and Dental Education)
Gut
March 1, 1995
10.1136/gut.36.3.411
Cited by 107

Related Papers

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
TRPV3 is a temperature-sensitive vanilloid receptor-like protein
|Nature|2002|851
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
|The Lancet Oncology|2017|780
Interleukin-12: Biological Properties and Clinical Application
|Clinical Cancer Research|2007|606
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
|The Lancet Oncology|2020|530